Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV.
about
Human telomerase contains two cooperating telomerase RNA molecules.RNase H activity: structure, specificity, and function in reverse transcriptionInsertion of a small peptide of six amino acids into the beta7-beta8 loop of the p51 subunit of HIV-1 reverse transcriptase perturbs the heterodimer and affects its activities.Processing sites in the human immunodeficiency virus type 1 (HIV-1) Gag-Pro-Pol precursor are cleaved by the viral protease at different rates.Conservation of functional domains and limited heterogeneity of HIV-1 reverse transcriptase gene following vertical transmissionSynthesis, Activity, and Structural Analysis of Novel α-Hydroxytropolone Inhibitors of Human Immunodeficiency Virus Reverse Transcriptase-Associated Ribonuclease HComplexes of HIV-1 RT, NNRTI and RNA/DNA hybrid reveal a structure compatible with RNA degradationIn vitro selection of variants of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosineComparison of inhibitory activities of various antiretroviral agents against particle-derived and recombinant human immunodeficiency virus type 1 reverse transcriptasesPhosphorothioate and cordycepin analogues of 2',5'-oligoadenylate: inhibition of human immunodeficiency virus type 1 reverse transcriptase and infection in vitroReplication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3'-azido-2'3'-dideoxythymidine (AZT) and other dideoxynuclSpecific HIV-1 reverse transcriptase inhibitorsInhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosidesAnti-(human immunodeficiency virus) activity of polyoxotungstates and their inhibition of human immunodeficiency virus reverse transcriptaseMechanism of resistance of human immunodeficiency virus type 1 to 2',3'-dideoxyinosineA new potent HIV-1 reverse transcriptase inhibitor. A synthetic peptide derived from the interface subunit domainsPotent nonnucleoside reverse transcriptase inhibitors target HIV-1 Gag-PolGag-Pol processing during HIV-1 virion maturation: a systems biology approachMutational sensitivity patterns define critical residues in the palm subdomain of the reverse transcriptase of human immunodeficiency virus type 1.Requirements for incorporation of Pr160gag-pol from human immunodeficiency virus type 1 into virus-like particles.Expression of soluble, enzymatically active, human immunodeficiency virus reverse transcriptase in Escherichia coli and analysis of mutants.A single amino acid substitution in HIV-1 reverse transcriptase significantly reduces virion release.Multiple nucleotide preferences determine cleavage-site recognition by the HIV-1 and M-MuLV RNases H.Subunit specificity of mutations that confer resistance to nonnucleoside inhibitors in human immunodeficiency virus type 1 reverse transcriptase.HIV-1 Transmission, Replication Fitness and Disease Progression.Construction and characterization of a temperature-sensitive human immunodeficiency virus type 1 reverse transcriptase mutantgag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants.Replication of phenotypically mixed human immunodeficiency virus type 1 virions containing catalytically active and catalytically inactive reverse transcriptase.Linker insertion mutagenesis of the human immunodeficiency virus reverse transcriptase expressed in bacteria: definition of the minimal polymerase domain.Structure and function of HIV-1 reverse transcriptase: molecular mechanisms of polymerization and inhibition.Mutations that abrogate human immunodeficiency virus type 1 reverse transcriptase dimerization affect maturation of the reverse transcriptase heterodimer.Structural characterization of reverse transcriptase and endonuclease polypeptides of the acquired immunodeficiency syndrome retrovirus.Analysis of human immunodeficiency virus type 1 reverse transcriptase subunit structure/function in the context of infectious virions and human target cells.Domain structure of the human immunodeficiency virus reverse transcriptase.Identification of alternative binding sites for inhibitors of HIV-1 ribonuclease H through comparative analysis of virtual enrichment studiesRecombinant p51 as antigen in an immune complex transfer enzyme immunoassay of immunoglobulin G antibody to human immunodeficiency virus type 1Comparison of the HIV-1 and HIV-2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag-Pol polyproteins.Vaccine and antiviral strategies against infections caused by human immunodeficiency virus.Conformational changes in HIV-1 reverse transcriptase induced by nonnucleoside reverse transcriptase inhibitor binding.Placement of leucine zipper motifs at the carboxyl terminus of HIV-1 protease significantly reduces virion production.
P2860
Q24291388-684808C9-6502-4889-A529-ED1E3C2319E3Q24643032-5783156C-B8A7-4F5E-A133-25CE60B8756BQ24796883-8AE97126-2206-4BED-AFC7-D2AA4A1F330BQ24812175-0B27F77C-536E-4426-869C-240C889F13B1Q24814895-114C0B93-D205-4E9B-8C8E-C1CC5FE33B24Q27667836-B8C7F12D-CBE6-4CE6-B725-1DE9A1171606Q27675888-86B348EF-4C93-4219-A5BC-C735EC58DF9EQ28324338-3C2F3145-28D6-43A7-BC57-0D9C69A7B8F6Q28339707-70D5ECE9-EFDF-4418-BD65-85FBBCC2B89DQ28340188-F1107A4D-0603-4E32-8386-F163E4E7D293Q28342341-40755261-19D9-471E-A639-74F12061D249Q28342783-4F5FF3DC-E12F-409A-8572-FF60B11BAF17Q28359853-6224DFAF-D4BD-42CA-8F54-823055CBAB56Q28367667-473CF9F9-1F6F-435F-839B-E6B77AE256AFQ28368041-71EAFFA5-347C-4C94-8252-42B4E688BCB0Q28371255-111C8AEF-31D6-4315-AE6F-8E16837BC296Q28469069-68342D6F-EEDD-4DDE-A884-32C14FCAFF2BQ28533696-F1DF81C0-7412-4897-9944-6A8390CA039AQ30416860-97044101-172F-4AAE-81C0-0804EAB7EB28Q30452154-FADE948C-DDFA-4F68-B4D1-2E9ACB665B69Q33554232-D39D18A8-2CD1-4689-A782-1DF12BCE5621Q33558367-D3ACBD5E-E0A0-4B05-AE98-163C1F8617E1Q33695787-B067D735-9DE6-4E99-A4C7-AAA2CAFC4E11Q33757596-CDB2FDE1-352D-4548-B962-5397FAAE7C37Q33758570-9D6AA499-0AA5-4186-A112-F5751B6EE082Q33782366-EDE9EACD-B3C2-420C-B64E-99BE9D735A27Q33782866-32B30C56-8BAF-4A25-9784-25DCE8448D9AQ33843501-807BB35D-A888-44BC-BAD1-2C04670615FEQ33852475-CAE8504C-483A-4C63-86DF-C0B5C22F971EQ33896402-68BCA917-BF39-45A8-B856-68918DEA0770Q33911895-CE3C4BB9-AFD3-4769-847F-B13DBFC1EF5EQ33929366-3E8ECFC3-CC12-45D9-9299-69299C2F6826Q33935269-3E2F6F6C-A0FE-404C-BDF4-7E753C18B416Q33937534-A64CB0EC-3B59-43F8-8AD9-F95CFCB4679FQ33945786-A4018F3C-C8F5-4E3E-8316-849D5A69B03AQ33998776-020B08A8-32A7-401A-9AEA-4B59AF58EC83Q34098983-2EDA5474-35D6-48FF-8006-8DBC88A71D11Q34101462-16C540C9-A449-41BF-A925-733FD08B2022Q34163065-F67E23AF-59B9-407E-8541-5A1B12E72A5CQ34187294-73C932C6-0B0F-4CCB-B6CA-1EED1FDF5746
P2860
Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV.
description
1986 nî lūn-bûn
@nan
1986 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի մարտին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
Characterization of highly imm ...... transcriptase of HTLV-III/LAV.
@ast
Characterization of highly imm ...... transcriptase of HTLV-III/LAV.
@en
Characterization of highly imm ...... transcriptase of HTLV-III/LAV.
@nl
type
label
Characterization of highly imm ...... transcriptase of HTLV-III/LAV.
@ast
Characterization of highly imm ...... transcriptase of HTLV-III/LAV.
@en
Characterization of highly imm ...... transcriptase of HTLV-III/LAV.
@nl
prefLabel
Characterization of highly imm ...... transcriptase of HTLV-III/LAV.
@ast
Characterization of highly imm ...... transcriptase of HTLV-III/LAV.
@en
Characterization of highly imm ...... transcriptase of HTLV-III/LAV.
@nl
P2093
P356
P1433
P1476
Characterization of highly imm ...... transcriptase of HTLV-III/LAV.
@en
P2093
Copeland TD
Oroszlan S
Sarngadharan MG
di Marzo Veronese F
P304
P356
10.1126/SCIENCE.2418504
P407
P50
P577
1986-03-01T00:00:00Z